02126.HK
JW (Cayman) Therapeutics Co. Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 2.22
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.74x
- Price / sales
- 2.75x
- Price / cash flow
- -7.17x
Enterprise value
- Enterprise value
- HKD 761.7M
- EV / sales
- 2.27x
- EV / EBITDA
- -3.24x
- EV / EBIT
- -2.38x
- Market cap
- HKD 923.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026